DRUG BINDING INTERFACES MAPPED TO 'ACRIFLAVINE RESISTANCE PROTEIN B'
List of Binding Interfaces (Click on the entry ID to view details of interfaces and pattern clusters) (Note that ASSAM search use only 3-12 residue containing patterns)DrReposER ID | PDB | Ligand | Organism | Macromolecule | Pfam | Res. | Interface | HETATM |
---|---|---|---|---|---|---|---|---|
1T9U_A_CPFA5002 | 1t9u | CPF DB00537(Ciprofloxacin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 6 | PHE A 664PHE A 666ASN A 667ARG A 717ASN A 719GLN A 830 | CPF A5002 |
1T9W_A_NFNA6001 | 1t9w | NFN DB00607(Nafcillin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 3 | SER A 96GLY A 97ARG A 468 | NFN A6001 |
1T9W_A_NFNA6002 | 1t9w | NFN DB00607(Nafcillin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 7 | MET A 575GLN A 577ALA A 618PHE A 664ARG A 717ASN A 719GLU A 722 | NFN A6002 |
2RDD_A_AICA1110 | 2rdd | AIC DB00415(Ampicillin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 4 | LYS A 29ALA A 384PHE A 386GLY A 387 | AIC A1110 |
3AOB_C_RFPC2002 | 3aob | RFP DB01045(Rifampicin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | no annotation | 12 | MET C 575GLN C 577PHE C 617ALA C 618THR C 624PHE C 664PHE C 666ARG C 717ASN C 719GLY C 720ARG C 815LEU C 828 | RFP C2002 |
3AOC_C_ERYC3402 | 3aoc | ERY DB00199(Erythromycin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | None | 15 | SER C 79THR C 91SER C 134SER C 135LYS C 292MET C 573MET C 575PHE C 615PHE C 617ILE C 626PHE C 666LEU C 674ASP C 681GLU C 683GLU C 826 | ERY C3402 |
3AOD_A_MIYA2001 | 3aod | MIY DB01017(Minocycline) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 8 | SER A 48PHE A 178GLY A 179GLU A 273ASN A 274ILE A 277ALA A 279PHE A 615 | MIY A2001 |
3AOD_C_RFPC2002 | 3aod | RFP DB01045(Rifampicin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | no annotation | 12 | MET C 575GLN C 577PHE C 617ALA C 618THR C 624PHE C 664PHE C 666ARG C 717ASN C 719GLY C 720ARG C 815LEU C 828 | RFP C2002 |
4DX5_B_MIYB1103 | 4dx5 | MIY DB01017(Minocycline) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | no annotation | 13 | SER B 48GLN B 151PHE B 178GLY B 179SER B 180GLU B 273ASN B 274ASP B 276ILE B 277ALA B 279VAL B 612PHE B 615ARG B 620 | MIY B1103 |
4DX7_A_DM2A1105 | 4dx7 | DM2 DB00445(Epirubicin)DB00997(Doxorubicin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 11 | MET A 575PHE A 617THR A 676GLY A 679ASP A 681ARG A 717ASN A 719ARG A 815GLU A 826GLN A 830MET A 862 | DM2 A1105 |
4DX7_A_DM2A1106 | 4dx7 | DM2 DB00445(Epirubicin)DB00997(Doxorubicin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | PF00873(ACR_tran) | 11 | SER A 134MET A 575PHE A 617PHE A 664PHE A 666ASN A 667LEU A 668THR A 676ALA A 677ARG A 717GLN A 830 | DM2 A1106 |
4DX7_B_DM2B1104 | 4dx7 | DM2 DB00445(Epirubicin)DB00997(Doxorubicin) | Escherichia coli | ACRIFLAVINERESISTANCE PROTEIN B | no annotation | 8 | SER B 46GLN B 89GLU B 130GLN B 176PHE B 178ILE B 277VAL B 612PHE B 615 | DM2 B1104 |